A Methadone Maintenance Treatment Outcome Study in Three Provinces in China
NCT ID: NCT01315054
Last Updated: 2024-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
4258 participants
INTERVENTIONAL
2011-05-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methadone Maintenance and HIV Prevention: A Window of Opportunity in China
NCT01532609
Behavioral Drug and HIV Risk Reduction Counseling With MMT in China
NCT01389180
Improving Methadone Maintenance Treatment Compliance and Outcomes in China
NCT01270113
Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients
NCT02991599
Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China
NCT00757744
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control arm
Using currently practiced methadone dosage prescription methods
national guidelines
Provided a hard copy of the existing national guidelines for methadone dosing
MMT provider dosage training
Intensive health care provider training on prescribing methadone dosage based on national guidelines
MMT provider dosage training
Training on methadone dosing provided to health care providers working in methadone maintenance clinics
national guidelines
Provided a hard copy of the existing national guidelines for methadone dosing
MMT provider dosage training/counseling
Intensive health care provider training on prescribing methadone dosage, plus providing on-site psychosocial counseling services and peer support to clients .
MMT provider dosage training
Training on methadone dosing provided to health care providers working in methadone maintenance clinics
targeted counseling
targeted counseling provided to methadone maintenance clinic attendees
national guidelines
Provided a hard copy of the existing national guidelines for methadone dosing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MMT provider dosage training
Training on methadone dosing provided to health care providers working in methadone maintenance clinics
targeted counseling
targeted counseling provided to methadone maintenance clinic attendees
national guidelines
Provided a hard copy of the existing national guidelines for methadone dosing
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
* residing in the study areas
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for AIDS/STD Control and Prevention, China CDC
OTHER_GOV
Centers for Disease Control and Prevention
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc Bulterys, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
US CDC GAP China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Center for HIV/STD Prevention and Control, China CDC
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CN_09_217
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
CDC-CGH-6014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.